Nature:组织因子和PAR1促进肠道菌群诱导的血管重塑

2012-03-31 Beyond 生物谷

瑞典哥德堡大学Sahlgrenska学院研究人员发现了肠道细菌影响血管形成的一种以前未知的机制。相关结果发表在《自然》杂志上,研究结果可能为未来肠道疾病和肥胖的治疗提供新思路。 我们的肠道细菌数量是人体细胞数量的十倍以上。然而,我们很少知道肠道菌群的功能以及这些菌群对我们生理上产生什么样的影响。 以前未知的机制 在小鼠动物模型的研究中,研究人员发现了肠道菌群如何影响肠道生理和血管重塑的以

瑞典哥德堡大学Sahlgrenska学院研究人员发现了肠道细菌影响血管形成的一种以前未知的机制。相关结果发表在《自然》杂志上,研究结果可能为未来肠道疾病和肥胖的治疗提供新思路。

我们的肠道细菌数量是人体细胞数量的十倍以上。然而,我们很少知道肠道菌群的功能以及这些菌群对我们生理上产生什么样的影响。

以前未知的机制

在小鼠动物模型的研究中,研究人员发现了肠道菌群如何影响肠道生理和血管重塑的以前未知的机制。研究结论为将来控制肠道吸收营养物质,治疗肠道疾病和肥胖等提供可能性。

新血管形成

研究侧重于绒毛,约一毫米长的手指状凸起,绒毛主要用于增加肠道表面积并最大限度地发挥其吸收养分的能力。在细菌存在情况下,这些绒毛演变成短而宽,意味着必须有新的血管形成。然而其中涉及到的机制此前一直不清楚。

研究员Fredrik Bckhed说:“我们的研究已经弄清楚正常肠道菌群发出的信号是如何让引发小肠中血管形成的”。简单来说,肠道细菌促进肠道粘膜细胞能接触到糖分子、特定的蛋白质。糖分子的作用就像邮编能移动到细胞表面,进而诱导信号传导。

将研究结果应用于临床方面,转换成新的疗法还需要很长时间。但我们的发现是令人兴奋的,基础研究结果让我们了解了正常肠道菌群是如何工作的。

Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.

Christoph Reinhardt, Mattias Bergentall, Thomas U. Greiner, Florence Schaffner, Gunnel ?stergren-Lundén, Lars C. Petersen, Wolfram Ruf, Fredrik Bckhed.

The gut microbiota is a complex ecosystem that has coevolved with host physiology. Colonization of germ-free (GF) mice with a microbiota promotes increased vessel density in the small intestine1, but little is known about the mechanisms involved. Tissue factor (TF) is the membrane receptor that initiates the extrinsic coagulation pathway2, and it promotes developmental and tumour angiogenesis3, 4. Here we show that the gut microbiota promotes TF glycosylation associated with localization of TF on the cell surface, the activation of coagulation proteases, and phosphorylation of the TF cytoplasmic domain in the small intestine. Anti-TF treatment of colonized GF mice decreased microbiota-induced vascular remodelling and expression of the proangiogenic factor angiopoietin-1 (Ang-1) in the small intestine. Mice with a genetic deletion of the TF cytoplasmic domain or with hypomorphic TF (F3) alleles had a decreased intestinal vessel density. Coagulation proteases downstream of TF activate protease-activated receptor (PAR) signalling implicated in angiogenesis5. Vessel density and phosphorylation of the cytoplasmic domain of TF were decreased in small intestine from PAR1-deficient (F2r-/-) but not PAR2-deficient (F2rl1-/-) mice, and inhibition of thrombin showed that thrombin–PAR1 signalling was upstream of TF phosphorylation. Thus, the microbiota-induced extravascular TF–PAR1 signalling loop is a novel pathway that may be modulated to influence vascular remodelling in the small intestine.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664387, encodeId=7be6166438e99, content=<a href='/topic/show?id=308be767080' target=_blank style='color:#2F92EE;'>#组织因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77670, encryptionId=308be767080, topicName=组织因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb9e25754903, createdName=12498bf3m33暂无昵称, createdTime=Sat Sep 08 11:00:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632984, encodeId=c090163298427, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Jun 29 14:00:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879157, encodeId=fffd18e9157b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 21 16:00:00 CST 2012, time=2012-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392128, encodeId=e02f1392128fb, content=<a href='/topic/show?id=223081e33b6' target=_blank style='color:#2F92EE;'>#肠道菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81733, encryptionId=223081e33b6, topicName=肠道菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa292500107, createdName=1249897bm37(暂无昵称), createdTime=Mon Apr 02 03:00:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664387, encodeId=7be6166438e99, content=<a href='/topic/show?id=308be767080' target=_blank style='color:#2F92EE;'>#组织因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77670, encryptionId=308be767080, topicName=组织因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb9e25754903, createdName=12498bf3m33暂无昵称, createdTime=Sat Sep 08 11:00:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632984, encodeId=c090163298427, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Jun 29 14:00:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879157, encodeId=fffd18e9157b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 21 16:00:00 CST 2012, time=2012-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392128, encodeId=e02f1392128fb, content=<a href='/topic/show?id=223081e33b6' target=_blank style='color:#2F92EE;'>#肠道菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81733, encryptionId=223081e33b6, topicName=肠道菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa292500107, createdName=1249897bm37(暂无昵称), createdTime=Mon Apr 02 03:00:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1664387, encodeId=7be6166438e99, content=<a href='/topic/show?id=308be767080' target=_blank style='color:#2F92EE;'>#组织因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77670, encryptionId=308be767080, topicName=组织因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb9e25754903, createdName=12498bf3m33暂无昵称, createdTime=Sat Sep 08 11:00:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632984, encodeId=c090163298427, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Jun 29 14:00:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879157, encodeId=fffd18e9157b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 21 16:00:00 CST 2012, time=2012-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392128, encodeId=e02f1392128fb, content=<a href='/topic/show?id=223081e33b6' target=_blank style='color:#2F92EE;'>#肠道菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81733, encryptionId=223081e33b6, topicName=肠道菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa292500107, createdName=1249897bm37(暂无昵称), createdTime=Mon Apr 02 03:00:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]
    2012-11-21 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664387, encodeId=7be6166438e99, content=<a href='/topic/show?id=308be767080' target=_blank style='color:#2F92EE;'>#组织因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77670, encryptionId=308be767080, topicName=组织因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb9e25754903, createdName=12498bf3m33暂无昵称, createdTime=Sat Sep 08 11:00:00 CST 2012, time=2012-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632984, encodeId=c090163298427, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Jun 29 14:00:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879157, encodeId=fffd18e9157b3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 21 16:00:00 CST 2012, time=2012-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392128, encodeId=e02f1392128fb, content=<a href='/topic/show?id=223081e33b6' target=_blank style='color:#2F92EE;'>#肠道菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81733, encryptionId=223081e33b6, topicName=肠道菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa292500107, createdName=1249897bm37(暂无昵称), createdTime=Mon Apr 02 03:00:00 CST 2012, time=2012-04-02, status=1, ipAttribution=)]